Related Experiment Video
Updated: May 31, 2026

A Choroid Plexus Epithelial Cell-based Model of the Human Blood-Cerebrospinal Fluid Barrier to Study Bacterial Infection from the Basolateral Side
Published on: May 6, 2016
Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems
Yung-Chi Chang1, Zhipeng Wang, Lindsay A Flax
1Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California, United States of America.
Abstract:
Certain microbes invade brain microvascular endothelial cells (BMECs) to breach the blood-brain barrier (BBB) and establish central nervous system (CNS) infection. Here we use the leading meningitis pathogen group B Streptococcus (GBS) together with insect and mammalian infection models to probe a potential role of glycosaminoglycan (GAG) interactions in the pathogenesis of CNS entry. Site-directed mutagenesis of a GAG-binding domain of the surface GBS alpha C protein impeded GBS penetration of the Drosophila BBB in vivo and diminished GBS adherence to and invasion of human BMECs in vitro. Conversely, genetic impairment of GAG expression in flies or mice reduced GBS dissemination into the brain. These complementary approaches identify a role for bacterial-GAG interactions in the pathogenesis of CNS infection. Our results also highlight how the simpler yet genetically conserved Drosophila GAG pathways can provide a model organism to screen candidate molecules that can interrupt pathogen-GAG interactions for future therapeutic applications.
Insights
Group B Streptococcus uses glycosaminoglycan (GAG) interactions to invade the central nervous system. Targeting these bacterial-GAG interactions may offer new therapies for meningitis and other CNS infections.
Area of Science:
- Microbiology
- Neuroscience
- Infectious Diseases
Background:
- Certain microbes breach the blood-brain barrier (BBB) by invading brain microvascular endothelial cells (BMECs).
- Group B Streptococcus (GBS) is a leading cause of meningitis and central nervous system (CNS) infection.
Purpose of the Study:
- To investigate the role of glycosaminoglycan (GAG) interactions in GBS entry into the CNS.
- To explore GAG-binding domains of GBS surface proteins as potential therapeutic targets.
Main Methods:
- Utilized insect (Drosophila) and mammalian infection models.
- Employed site-directed mutagenesis of the GAG-binding domain of GBS alpha C protein.
- Assessed GBS adherence and invasion of human BMECs in vitro.
- Genetically impaired GAG expression in model organisms.
Main Results:
- Mutagenesis of the GAG-binding domain impeded GBS penetration of the Drosophila BBB and reduced adherence/invasion of human BMECs.
- Impaired GAG expression in flies and mice decreased GBS dissemination into the brain.
- Bacterial-GAG interactions were identified as crucial for CNS infection pathogenesis.
Conclusions:
- Bacterial-GAG interactions play a significant role in the pathogenesis of CNS infections like meningitis.
- Drosophila serves as a valuable model for screening therapeutic molecules targeting pathogen-GAG interactions.
- Interruption of GAG-binding domains presents a potential strategy for preventing CNS entry of pathogens.
Related Concept Videos
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology
Determinants of Bacterial Pathogenicity and Virulence
Colonisation of Pathogens
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Proteoglycans

